An Open-Label Study to Investigate the Safety and Efficacy of Rotigotine Add-On Therapy With Low Doses of Pramipexole or Ropinirole in Patients With Advanced Parkinson's Disease Phase 3B
Phase of Trial: Phase III
Latest Information Update: 14 Jul 2014
At a glance
- Drugs Rotigotine (Primary) ; Pramipexole; Ropinirole
- Indications Parkinson's disease
- Focus Therapeutic Use
- 31 Aug 2018 Biomarkers information updated
- 01 Apr 2013 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 21 Mar 2013 Planned End Date changed from 1 Mar 2013 to 1 Apr 2013 as reported by ClinicalTrials.gov.